Showing results (11-20 of 56) with videos related to
Sort By:
Pageof 6
Neuropathology : Official Journal of the Japanese Society of Neuropathology|June 6, 2025
Fatal Outcome of Intravenous Thrombolysis With an Unexpected Finding of Amyloid-β-Related Angiitis-A Case Report Highlighting a Relevant Scenario With Acute Focal Neurological Deficits and Minimal Radiological PresentationKristof Babarczy, Bence L Radics, Orsolya Horvath, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|March 21, 2020
Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathyBernadett Fakan, Zita Reisz, Denes Zadori, et al.Current Topics in Medicinal Chemistry|October 4, 2012
Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunctionLevente Szalardy, Denes Zadori, Jozsef Toldi, et al.Journal of Neurochemistry|January 15, 2004
Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosisPeter Klivenyi, Mahmoud Kiaei, Gabrielle Gardian, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|May 11, 2020
Correction to: Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathyBernadett Fakan, Zita Reisz, Denes Zadori, et al.Medicinal Chemistry (Shariqah (United Arab Emirates))|May 17, 2007
Peripheral kynurenine metabolism in focal dystoniaZsuzsanna Hartai, Peter Klivenyi, Tamas Janaky, et al.Journal of Molecular Neuroscience : MN|December 4, 2003
Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's diseasePeter Klivenyi, Gabrielle Gardian, Noel Y Calingasan, et al.Journal of the Neurological Sciences|August 16, 2005
Kynurenine metabolism in plasma and in red blood cells in Parkinson's diseaseZsuzsanna Hartai, Peter Klivenyi, Tamas Janaky, et al.Journal of the Neurological Sciences|May 28, 2013
Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severityLevente Szalardy, Denes Zadori, Mihaela Simu, et al.Journal of Human Genetics|October 14, 2016
Novel AARS2 gene mutation producing leukodystrophy: a case reportLaszlo Szpisjak, Nora Zsindely, Jozsef I Engelhardt, et al.Pageof 6